Jefferies Raises Immutep Target to A$0.08/Share From A$0.04/Share

Généré parAinvest NewsRévisé parThe Newsroom
lundi 14 septembre 2026 20:14 ET1 min de lecture
IMMP--
Jefferies has raised Immutep's target price to A$0.08 per share from A$0.04, citing the company's progress in clinical trials and potential for the treatment of cancer. The stock price has increased by 50% in the past month.

Commentaires



Aucun commentaire

Pas encore de commentaires